AbbVie | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Abbott USD 13.44B 435M 2025-06
ALKERMES USD 505.96M 62.23M 2025-06
Amgen USD 23.01B 91M 2025-03
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.38B 453M 2025-06
J&J USD 56.9B 6.58B 2025-03
Medtronic USD 12.88B 1.04B 2025-04
Merck USD 25.17B 3.25B 2025-03
Neurocrine Biosciences USD 546.3M 23.4M 2025-06
Novartis USD 31.71B 95M 2025-06
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03
UCB EUR 3.53B 731M 2024-12
Ultragenyx Pharmaceutical USD 344.15M 59.14M 2024-12
United Therapeutics USD 527.1M 194.4M 2025-06
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Zoetis USD 3.38B 27M 2025-03


AbbVie Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.